Cedars-Sinai Launches Health Sciences University

Cedars-Sinai in Los Angeles has established Cedars-Sinai Health Sciences University to prepare academic scientists, physician leaders and allied health professionals for the future of healthcare and biomedical science, highlighted by a new Ph.D. program in health artificial intelligence.

Cedars-Sinai already is home to more than 315 graduate students and postdoctoral scientists and 540 medical residents and fellows. Current students can earn a Ph.D. in biomedical and translational sciences and master’s of science degrees in health systems and magnetic resonance in medicine.

The Ph.D. in health AI will offer rigorous training in AI algorithms and methods, with a focus on analyzing clinical data to enhance patient care, according to the hospital system. The hands‑on, active approach to teaching will reinforce AI concepts through clinical rotations and scholarly collaboration with physicians and medical staff. Graduates will be positioned to directly improve healthcare and patient outcomes through the rigorous development and deployment of AI algorithms and software.

Cedars‑Sinai's Ph.D. degree program in Health AI is pending WSCUC accreditation.

Also new is the Chuck Lorre School of Allied Health, established with a $30 million gift from the Chuck Lorre Family Foundation to offer allied healthcare careers for individuals in historically marginalized groups in Los Angeles and beyond. In the first phase of this program, students will earn a bachelor of science degree in respiratory therapy or certification in one of three other high-demand technical specialties that are chronically understaffed in hospitals: pharmacy technician, clinical laboratory scientist and radiation therapy technician. 

The allied health programs are pending accreditation from the Western Association of Schools and Colleges (WASC).

“The new Health Sciences University builds on Cedars-Sinai’s legacy to foster continual learning as a way to improve the health of communities,” said Peter L. Slavin, M.D., president and CEO of Cedars-Sinai Medical Center and Cedars-Sinai Health System, in a statement. “We are proudly committed to developing high-achieving academic investigators and educators in disease-focused science.”